All 252 IBB (ISHARES BIOTECHNOLOGY ETF) Holdings
There are 252 IBB holdings. Top 10 companies weight: 44.73%.
Total Market Cap: $1.60T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (252 stocks) | +19.98% | 23.69 | 17.29 | 0.53 | +25.34% | +9.82% | 0.81 | ||||||||||
101 | ANAB | Anaptysbio Inc | 0.14% | $53.76 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +62.00% | $87 | +25.59% | 0.81 |
102 | ZLAB | Zai Lab Ltd Adr Repr 1 Shs | 0.13% | $20.48 | $2.27B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +62.60% | $33 | -33.79% | 0.91 |
103 | TRVI | Trevi Therapeutics Inc | 0.13% | $18.18 | $2.33B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 80 | +36.96% | $25 | +55.03% | 0.66 |
104 | NVCR | Novocure Ltd | 0.13% | $16 | $1.86B | Medical Devices | Healthcare | N/A | N/A | 909.09 | N/A | N/A | N/A | 71 | +55.50% | $25 | -39.03% | 1.37 |
105 | STOK | Stoke Therapeutics Inc | 0.13% | $28.81 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +59.04% | $46 | -1.54% | 1.05 |
106 | SNDX | Syndax Pharmaceuticals Inc | 0.13% | $22.64 | $2.08B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +72.26% | $39 | +9.02% | 1.03 |
107 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.13% | $3.08 | $1.76B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +135.39% | $7.25 | -38.84% | 2.63 |
108 | MLYS | Mineralys Therapeutics Inc | 0.13% | $27.52 | $2.43B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +78.05% | $49 | 0.00% | 0.77 |
109 | FTRE | Fortrea Holdings Inc | 0.13% | $17.91 | $1.69B | Biotechnology | Healthcare | N/A | N/A | 13.87 | 0.34 | N/A | N/A | 52 | -3.69% | $17 | 0.00% | 1.87 |
110 | AMLX | Amylyx Pharmaceuticals Inc | 0.13% | $18.50 | $1.97B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +33.51% | $25 | 0.00% | 1.14 |
111 | MBX | Mbx Biosciences Inc | 0.13% | $60.28 | $2.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +14.47% | $69 | 0.00% | 1.44 |
112 | TSHA | N/A | 0.12% | $5.67 | $1.78B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +129.28% | $13 | -21.91% | 1.42 |
113 | NVAX | Novavax Inc | 0.12% | $8.07 | $1.39B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +74.74% | $14 | -47.88% | 1.45 |
114 | GRFS | Grifols Sa Adr | 0.12% | $7.75 | $4.91B | Drug Manufacturers - General | Healthcare | -10.20% | 10.11 | 8.40 | 0.08 | N/A | N/A | 62 | +40.26% | $11 | -12.03% | 0.85 |
115 | ABSI | Absci Corp | 0.12% | $8.32 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +65.62% | $14 | -17.36% | 2.33 |
116 | IOVA | Iovance Biotherapeutics Inc | 0.12% | $5.48 | $2.08B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +60.58% | $8.80 | -25.11% | 1.60 |
117 | CMPS | Compass Pathways Plc Adr | 0.11% | $12.18 | $1.80B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +100.90% | $24 | -19.88% | 1.38 |
118 | CDNA | Caredx Inc | 0.11% | $38.54 | $1.53B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | -14.37% | $33 | -14.57% | 1.27 |
119 | GLUE | Monte Rosa Therapeutics Inc | 0.11% | $23.63 | $1.97B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +40.37% | $33 | +1.29% | 1.31 |
120 | ATAI | Ataibeckley Inc | 0.11% | $7.14 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -16.19% | N/A |
121 | URGN | Urogen Pharma Ltd | 0.11% | $43.78 | $1.94B | Biotechnology | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 75 | -4.93% | $42 | +22.30% | 1.19 |
122 | NUVB | N/A | 0.10% | $6.43 | $2.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +91.76% | $12 | -5.58% | 1.47 |
123 | GHRS | Gh Research Plc | 0.10% | $28.35 | $1.67B | Biotechnology | Healthcare | +89.13% | N/A | N/A | N/A | N/A | N/A | 83 | +39.33% | $40 | +9.51% | 0.92 |
124 | IMCR | Immunocore Holdings Plc Adr | 0.10% | $34.48 | $1.76B | Biotechnology | Healthcare | N/A | N/A | 232.56 | N/A | N/A | N/A | 69 | +83.79% | $63 | -0.13% | 0.70 |
125 | VIR | Vir Biotechnology Inc | 0.10% | $9.42 | $1.55B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +128.87% | $22 | -24.08% | 1.52 |
126 | TYRA | Tyra Biosciences Inc | 0.10% | $31.85 | $1.93B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +63.17% | $52 | 0.00% | 1.02 |
127 | LKFT | Lakefront Biotherapeutics Nv Adr | 0.10% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
128 | AVBP | Arrivent Biopharma Inc | 0.09% | $28.26 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
129 | SION | Sionna Therapeutics Inc | 0.09% | $47.21 | $2B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 68 | +9.30% | $52 | 0.00% | 0.90 |
130 | RAPP | Rapport Therapeutics Inc | 0.09% | $42.56 | $1.91B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +33.08% | $57 | 0.00% | 1.27 |
131 | MNKD | Mannkind Corp | 0.09% | $4.05 | $1.26B | Biotechnology | Healthcare | -21.18% | N/A | 42.37 | 4.39 | N/A | N/A | 71 | +87.41% | $7.59 | -2.00% | 0.71 |
132 | MESO | Mesoblast Ltd Adr | 0.08% | $16.42 | $2.36B | Biotechnology | Healthcare | -15.82% | N/A | 454.55 | N/A | N/A | N/A | 91 | +113.15% | $35 | +2.75% | 1.39 |
133 | PHVS | Pharvaris Nv Ordinary Shares | 0.08% | $34.45 | $2.30B | Biotechnology | Healthcare | +9.20% | N/A | N/A | N/A | N/A | N/A | 78 | +37.10% | $47 | +18.99% | 0.66 |
134 | BCAX | Bicara Therapeutics Inc | 0.08% | $28.15 | $1.84B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
135 | INBX | Inhibrx Biosciences Inc | 0.08% | $87.61 | $1.33B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +216.74% | $278 | 0.00% | 1.39 |
136 | MAZE | Maze Therapeutics Inc | 0.08% | $29.30 | $1.46B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +113.48% | $63 | 0.00% | 0.87 |
137 | WVE | Wave Life Sciences Ltd | 0.08% | $5.79 | $1.14B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +278.93% | $22 | -2.17% | 1.46 |
138 | XNCR | Xencor Inc | 0.08% | $20.45 | $1.11B | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +38.53% | $28 | -8.77% | 1.43 |
139 | REPL | Replimune Group Inc | 0.07% | $11 | $801M | Biotechnology | Healthcare | +16.21% | N/A | N/A | N/A | N/A | N/A | 56 | -3.00% | $11 | -19.74% | 0.74 |
140 | ZBIO | Zenas Biopharma Inc | 0.07% | $32.36 | $1.83B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +30.16% | $42 | 0.00% | 1.25 |
141 | CRVS | Corvus Pharmaceuticals Inc | 0.07% | $14.47 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +130.34% | $33 | +43.84% | 0.76 |
142 | STVN | Stevanato Group Spa | 0.07% | $19.10 | $5.16B | Medical Instruments & Supplies | Healthcare | +7.16% | 31.25 | 31.95 | 1.37 | N/A | N/A | 75 | +28.01% | $24 | -0.47% | 0.86 |
143 | SEPN | Septerna Inc | 0.07% | $33.68 | $1.53B | Biotechnology | Healthcare | N/A | N/A | 107.53 | N/A | N/A | N/A | 77 | +33.61% | $45 | 0.00% | 1.24 |
144 | PSNL | Personalis Inc | 0.07% | $13.44 | $1.65B | Diagnostics & Research | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 75 | -1.12% | $13 | -9.37% | 2.30 |
145 | KURA | Kura Oncology Inc | 0.07% | $10.89 | $1.01B | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +186.23% | $31 | -10.12% | 1.06 |
146 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.07% | $16.26 | $976M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +128.72% | $37 | -11.75% | 1.20 |
147 | OLMA | N/A | 0.07% | $11.59 | $1.03B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +251.16% | $41 | -14.19% | 0.72 |
148 | MGTX | Meiragtx Holdings Plc | 0.07% | $12.52 | $1.02B | Biotechnology | Healthcare | -1.60% | N/A | 1.62 | N/A | N/A | N/A | 81 | +126.68% | $28 | -3.01% | 1.29 |
149 | ZVRA | Zevra Therapeutics Inc | 0.06% | $12.45 | $766M | Biotechnology | Healthcare | N/A | 5.89 | 11.93 | 10.67 | N/A | N/A | 80 | +124.02% | $28 | +2.53% | 0.65 |
150 | TBPH | Theravance Biopharma Inc | 0.06% | $16.84 | $872M | Biotechnology | Healthcare | N/A | 12.26 | 7.91 | N/A | N/A | N/A | 55 | +4.93% | $18 | +4.12% | 0.53 |
IBB (ISHARES BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
94.30%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%